Keywords: enzon, r-pr, single-chain, antigen-binding, protein, deal, granted

Enzon / R-PR single-chain antigen-binding protein deal

Article | 15 January 1996

- Enzon has granted Rhone-Poulenc Rorer worldwide, non-exclusive rights to its single-chain antigen-binding protein technology - compounds which target specific molecules ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in